Research news

A clinical trial at UCLH will investigate whether a new type of immune therapy can prevent colorectal cancer from returning.

Over 150 people visited a highly successful health and research engagement event in Camden which engaged the local community in healthcare innovation, research, and how to stay healthy.

An immunotherapy drug given before surgery instead of chemotherapy meant that significantly more patients with a certain genetic profile were cancer free after surgery, according to clinical trial results presented by researchers at UCL and UCLH.

UCLH’s trial of the world’s first ‘gene silencing’ drug for Alzheimer’s disease has progressed into a larger and later stage trial, after promising early results.

A world-class research team at UCLH and UCL has been awarded £3.76m to carry out a countrywide trial to identify accurate and quick blood tests that can diagnose dementia.